ey0016.13-5 | Diabetes | ESPEYB16
EL Klatman
, AJ Jenkins
, MY Ahmedani
, GD Ogle
Lancet Diabetes Endocrinol 2019; 7: 15060. DOI 10.1016/S2213-8587(18)30074-3• Access to blood glucose monitoring is often poor in resource-limited settings.• The authors analyse the reasons for suboptimal access, with a focus on cost, availability, system accuracy, competitive bidding, technological trends, and non-financial barriers. Urine gl...